TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Clinical trial NCT03686488 · COMPLETED
Trial details
- NCT number
- NCT03686488
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2022-01-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.